Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128792 | 0.79 | — | — | |
| SCHEMBL444614 | 0.77 | NPSR1 (0.36) | NPSR1 | |
| SCHEMBL10876044 | 0.77 | NPSR1 (0.36) | NPSR1 | |
| SCHEMBL9436420 | 0.77 | NPSR1 (0.36) | NPSR1 | |
| SCHEMBL14635334 | 0.76 | TSHR (0.50) | NPSR1 | |
| Sulfuric Acid SCHEMBL29289482 | 0.76 | NPSR1 (0.46) | NPSR1 | |
| Sulfuric Acid SCHEMBL78884 | 0.76 | NPSR1 (0.46) | NPSR1 | |
| Sulfuric Acid SCHEMBL11137355 | 0.76 | NPSR1 (0.46) | NPSR1 | |
| Sulfuric Acid SCHEMBL16059228 | 0.76 | NPSR1 (0.46) | NPSR1 | |
| Sulfuric Acid SCHEMBL11137352 | 0.76 | NPSR1 (0.46) | NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1392671-B1 | PROCESS FOR THE PREPARATION OF ISOFLAVONES | DSM IP ASSETS BV (NL) | 2008-02-27 | — | — | EP | disclosed |
| US-7109358-B2 | Process for the preparation of isoflavones | DSM IP ASSETS B.V. (NL) | 2006-09-19 | — | — | US | disclosed |
| US-20040158082-A1 | Process for the preparation of isoflavones | HUMANETICS CORPORATION | 2004-08-12 | — | — | US | disclosed |
| EP-1392671-A1 | PROCESS FOR THE PREPARATION OF ISOFLAVONES | Roche Vitamins AG (CH) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002085881-A1 | PROCESS FOR THE PREPARATION OF ISOFLAVONES | ROCHE VITAMINS AG (CH) | 2002-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040158082-A1 | Process for the preparation of isoflavones | CYP2F1, PCSK6, SULT2A1 | NPSR1 1791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.